Furthermore, a recent study reports AD neuropathology (including tau) increases dramatically in APOE44 individuals from age 50, with dementia symptoms emerging earlier (mean age 65.6 years) in this high‐risk group.31 The gene discussed is MAPT; the disease is Alzheimer disease.